Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Efficacy and safety of bortezomib in refractory lupus nephritis: a single-center experience.

Segarra A, Arredondo KV, Jaramillo J, Jatem E, Salcedo MT, Agraz I, Ramos N, Carnicer C, Valtierra N, Ostos E.

Lupus. 2020 Feb;29(2):118-125. doi: 10.1177/0961203319896018. Epub 2019 Dec 22.

PMID:
31865857
2.

Mesangial C4d Deposits in Early IgA Nephropathy.

Segarra A, Romero K, Agraz I, Ramos N, Madrid A, Carnicer C, Jatem E, Vilalta R, Lara LE, Ostos E, Valtierra N, Jaramillo J, Arredondo KV, Ariceta G, Martinez C.

Clin J Am Soc Nephrol. 2018 Feb 7;13(2):258-264. doi: 10.2215/CJN.02530317. Epub 2017 Nov 16.

3.

Evolution of antibody titre against the M-type phospholipase A2 receptor and clinical response in idiopathic membranous nephropathy patients treated with tacrolimus.

Segarra-Medrano A, Jatem-Escalante E, Carnicer-Cáceres C, Agraz-Pamplona I, Salcedo MT, Valtierra N, Ostos-Roldán E, Arredondo KV, Jaramillo J.

Nefrologia. 2014;34(4):491-7. doi: 10.3265/Nefrologia.pre2014.Jun.12536. English, Spanish.

Supplemental Content

Loading ...
Support Center